The Hidden Inventory
22nd Century Group, Inc. (NASDAQ: XXII) reports 713,994 shares outstanding and a 599,493-share public float. Both figures are accurate — and both dramatically understate the company's real equity supply.
On August 13, 2026, all 3,019,586 of the company's outstanding inducement warrants were repriced to $0.3675 and exercised on a cashless basis — meaning the holders surrendered the warrants' intrinsic value in lieu of cash, receiving shares instead of paying the exercise price. The exercise produced 2,742,397 shares. Only 211,155 were actually issued. The remaining 2,531,242 are held in abeyance: fully paid for, registered for resale on effective S-3 (File No. 333-296761), and deliverable to holders Anson Funds, Iroquois Capital, SEG Opportunity Fund, and Dawson James Securities whenever their beneficial-ownership blockers — contractual caps at 4.99% or 9.99% of outstanding shares — permit.
Those abeyance shares equal 4.2 times the entire quoted float. No data service reflects them.
What the Data Services Miss
Every float-derived metric on this ticker — short interest as a percentage of float, days to cover, float rotation — is computed against 599,493 shares. Effective supply, including abeyance shares, is approximately 3,130,735. That is a 5.2x gap. The shares require no further company action, no additional SEC filing, and no board approval to enter the market. They drip in as holders sell down beneath their ownership caps.
The Overhang Behind the Overhang
Abeyance shares are only the nearest layer. On August 5, 2026, stockholders approved two additional offerings closable within three months:
- Up to $20 million in new floating-rate convertible preferred stock, convertible at 85% of the lowest 20-day VWAP — meaning the conversion price drops automatically as the stock weakens — with a floor set at just 20% of the Nasdaq Minimum Price at signing.
- Up to $10 million of common stock or pre-funded warrants — instruments priced just below the share price so they function like shares but avoid blocker-cap accounting — plus $10 million of price-reset warrants.
That is $30–40 million of authorized issuance. The company's market capitalization is $2.2 million.
The Structural Backdrop
Six reverse splits in 37 months have compressed the share count by a cumulative factor of roughly 1-for-16.5 million. A seventh — ranging from 1-for-2 to 1-for-200 — was authorized on August 5 and is executable at board discretion through August 2028. The June 2026 split itself triggered anti-dilution clauses that manufactured 2,752,302 additional inducement warrants and a $17 million deemed dividend.
The Series B Convertible Preferred — 8,505 shares with $8.505 million in stated value — carries a variable conversion rate at a 15% discount to the lowest daily VWAP over the prior 20 trading days. Its $14.28 floor price currently blocks conversion, sitting 4.6 times above the market. But the company has historically removed exactly that brake: in December 2025, the Series A preferred's floor was retroactively overridden via an omnibus amendment.
Insider alignment is negligible. All eight directors and officers combined hold a total of 8 shares.
Dilution Risk Grade: 8 out of 10 (HIGH)
The score reflects completed but undelivered dilution at 4.2 times the float, a 5,735% twelve-month increase in split-adjusted shares outstanding, stockholder-authorized offerings sized at roughly 15 times market cap, and a capital structure controlled almost entirely by structured-finance counterparties with registered resale rights and participation rights on future deals. The only factor holding the score below the maximum: zero warrants remain outstanding and the Series B's floor currently prevents conversion — two constraints this issuer has repeatedly reset through reverse splits and replacement offerings in the past.